Ranbaxy Laboratories Ltd has announced the following results for the quarter & Fifteen months ended March 31, 2014:
The Audited results for the Quarter ended March 31, 2014
The Company has posted a net profit of Rs. 8978.59 million for the Quarter ended March 31, 2014 where as the same was at Rs. 701.47 million for the Quarter ended March 31, 2013. Total Income is Rs. 18885.18 million for the Quarter ended March 31, 2014 where as the same was at Rs. 14339.62 million for the Quarter ended March 31, 2013.
The Figures for the Quarter ended March 31, 2013 are Unaudited.
The Audited results for the Fifteen months ended March 31, 2014
The Company has posted a net loss of Rs. (8789.95) million for the Fifteen months ended March 31, 2014. Total Income is Rs. 76497.57 million for the Fifteen months ended March 31, 2014
- The Board of Directors vide resolution dated October 29, 2013 has approved the change of financial year of the Company from January - December to April - March effective April 01, 2014. In view of this, the current financial year is for a period of 15 months i.e. January 01, 2013 to March 31, 2014 and, accordingly, the figures for the fifteen months ended March 31, 2014 are not comparable with the figures for the year ended December 31, 2012.
The Consolidated Results are as follows :
The Audited Consolidated results for the Quarter ended March 31, 2014
The Group has posted a net loss after taxes, minority interest and consolidated share in profit / (loss) of associate of Rs. (736.54) million for the Quarter ended March 31, 2014 where as the same was at net profit of Rs. 1257.59 million for the year ended March 31, 2013. Total Income is Rs. 24905.19 million for the year ended March 31, 2014 where as the same was at Rs. 25342.52 million for the year ended March 31, 2013.
The Figures for the Quarter ended March 31, 2013 are Unaudited.
The Audited Consolidated results for the Fifteen months ended March 31, 2014
The Group has posted a net loss after taxes, minority interest and consolidated share in profit / (loss) of associate of Rs. (10852.52) million for the Fifteen months ended March 31, 2014. Total Income is Rs. 134513.16 million for the Fifteen months ended March 31, 2014.
- The Board of Directors vide resolution dated October 29, 2013 has approved the change of financial year of the Company from January - December to April - March effective April 01, 2014. In view of this, the current financial year is for a period of 15 months i.e. January 01, 2013 to March 31, 2014 and, accordingly, the figures for the fifteen months ended March 31, 2014 are not comparable with the figures for the year ended December 31, 2012.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
